Previously, we reported that miR‐429 negatively regulates CRKL expression in HCC and ccRCC cells by selectively targeting its 3′‐UTR at the 3728‐3735 bp site and the upregulation of CRKL negatively correlated with miR‐429 deficiency potentially promoted the development and progression of HCC/ccRCC patients and the aggressiveness of HCC/ccRCC cells.40, 41. The gene discussed is CRKL; the disease is hepatocellular carcinoma.